Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
type
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

224467

	registered interest
	date	02/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Brain Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps the Government has taken to improve brain cancer patients' access to cancer drugs.
	tabling member constituency	Windsor
	tabling member printed	Adam Afriyie
	type	WrittenParliamentaryQuestion
	uin	225805
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The Government is committed to ensuring that patients have access to effective treatments, including those for brain cancers, on terms that represent value to the National Health Service and the taxpayer.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. NICE has recommended the following drugs for brain cancers as treatment options, subject to certain clinical criteria, in its technology appraisal guidance published in June 2007:</p><p> </p><p> </p><p> </p><p>- temozolomide (Temodal) for the treatment of newly diagnosed glioblastoma multiforme (GBM); and</p><p> </p><p> </p><p> </p><p>- carmustine (Gliadel) implants, for the treatment of newly diagnosed high-grade glioma.</p><p> </p><p> </p><p> </p><p>NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance.</p><p> </p><p><em> </em></p><p> </p><p>Where a drug to treat brain cancer is not routinely available on the NHS, patients may be able to access it through the Cancer Drugs Fund. Bevacizumab (Avastin) is available for the third line treatment of low grade paediatric gliomas through the Fund.</p><p> </p><p> </p><p> </p><p>We are also commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/03/2015 12:44:29 answering member 4020 label Biography information for George Freeman
	tabling member	1586 label Biography information for Adam Afriyie

225193

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to increase the number of diabetics who are offered structured courses to help them self-manage their diabetes.
	tabling member constituency	Bristol North West
	tabling member printed	Charlotte Leslie
	type	WrittenParliamentaryQuestion
	uin	226406
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>NHS England’s Action for Diabetes makes it clear that if we are to improve the health outcomes of people living with diabetes, we must improve individuals’ personal management of their condition and empower them to take charge of their own care.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence Quality Standard for diabetes sets out that people with diabetes should receive a structured educational programme. NHS England is statutorily required to have regard to this. NHS England aims to use the new indicator in the Quality and Outcomes Framework and the new best practice tariff to promote provision of structured education for those with diabetes.</p><p> </p><p> </p><p> </p><p>There are a number of national and locally developed patient education programmes available including Dose Adjustment For Normal Eating (DAFNE) for Type 1 diabetes, and Diabetes Education and Self-management for Ongoing and Newly Diagnosed (DESMOND) for Type 2 diabetes. A range of tools and guidance to help local services choose the best programmes to meet the needs of their local population is also available, for example the web based Transforming Participation in Health and Care tool.</p><p> </p><p> </p><p> </p><p>The proportion of people with diabetes being offered structured education is improving. 16% of people newly diagnosed with diabetes were offered structured education in 2012/13 compared to 8.4% of those diagnosed in 2009. In the same period the number of people newly diagnosed with diabetes offered or attending structured education rose from 11% to 18.4%.</p><p> </p><p><strong> </strong></p><p> </p><p>Public Health England, NHS England and Diabetes UK are currently working together to establish a national diabetes prevention programme, making us the first country to implement such a programme at scale, modelled on national and international proven experience.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/03/2015 16:57:58 answering member 3918 label Biography information for Jane Ellison
	tabling member	3933 label Biography information for Charlotte Leslie

225198

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Care Workers: English Language
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that care workers in the NHS have a sufficient level of English language proficiency to understand and communicate medical terminology.
	tabling member constituency	Bristol North West
	tabling member printed	Charlotte Leslie
	type	WrittenParliamentaryQuestion
	uin	226322
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>It is the responsibility of the local National Health Service or care sector employer to carry out any relevant checks to satisfy themselves that any potential employee has the required level of communication skills for their role.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 09/03/2015 15:48:34 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	3933 label Biography information for Charlotte Leslie

224729

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Brain: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will fund research on using a skin test to detect hard-to-spot brain diseases.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	type	WrittenParliamentaryQuestion
	uin	226008
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The Department's National Institute for Health Research welcomes funding applications for research into any aspect of human health, including tests for biological markers of brain diseases. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/03/2015 12:44:58 answering member 4020 label Biography information for George Freeman
	tabling member	1597 label Biography information for David Simpson

225107

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that public funding allocated to licensed independent sector places for the termination of pregnancy is not used to campaign for changes in UK law; and if he will make a statement.
	tabling member constituency	Congleton
	tabling member printed	Fiona Bruce
	type	WrittenParliamentaryQuestion
	uin	226286
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>Clinical commissioning groups are responsible for the contracting of independent sector places to perform termination of pregnancy.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/03/2015 16:11:18 answering member 3918 label Biography information for Jane Ellison
	tabling member	3958 label Biography information for Fiona Bruce

225192

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average waiting time for mental health talking therapies is in (a) the North West and (b) Warrington.
	tabling member constituency	Warrington North
	tabling member printed	Helen Jones
	type	WrittenParliamentaryQuestion
	uin	226419
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The information is not available in the format requested. Such information as is available is shown in the following table. The Improving Access to Psychological Therapies (IAPT) dataset contains information on referrals to IAPT services which provide talking therapies. Information is provided both for Warrington Clinical Commissioning Group (CCG) and for all 33 North West CCGs combined for the year 2013/14.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p> </p><table><tbody><tr><td colspan="4"><p>The number of referrals entering treatment<sup>1</sup> in the year, with mean and median waiting times (days), for IAPT<sup>2</sup> services in 2013/14. Data shown for NHS Warrington CCG and all North West CCGs combined<sup>3</sup>.</p></td><td> </td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><p>Organisation name</p></td><td><p>Referrals<sup>4</sup> entering treatment</p></td><td><p>Mean<sup>5</sup> waiting time to first treatment appointment (days)</p></td><td><p>Median<sup>5</sup> waiting time to first treatment appointment (days)</p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><p>NHS Warrington CCG</p></td><td><p>3,250</p></td><td><p>42</p></td><td><p>21</p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><p>All North West CCGs combined</p></td><td><p>94,775</p></td><td><p>55</p></td><td><p>26</p></td><td> </td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4"><p><em>Notes:</em></p><p><sup>1</sup>In order to enter treatment a referral must have a first treatment appointment (an appointment with a therapy type recorded) in the year.</p></td><td> </td></tr><tr><td colspan="4"><p><sup>2</sup>IAPT services are psychological therapies services commissioned by the NHS through the IAPT programme.</p></td><td> </td></tr><tr><td colspan="4"><p><sup>3</sup>CCG is based on general practitioner (GP) Practice. Where GP Practice is not recorded, or cannot be assigned to a CCG, the referral is categorised as 'Unknown'.</p></td><td> </td></tr><tr><td colspan="4"><p><sup>4</sup>This is not distinct people, as a person can have more than one referral.</p></td><td> </td></tr><tr><td colspan="4"><p><sup>5</sup>Means and medians have been rounded to the nearest whole number.</p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4" rowspan="2"><p>Waiting time is measured by counting the number of days between a referral being received and the first treatment appointment. For 2013/14, the presence of a valid therapy type is used as an indicator of whether treatment was provided in the course of the appointment.</p></td><td> </td></tr><tr><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4"><p>Entering treatment figures are rounded to the nearest 5, except for England totals.</p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4"><p>It is generally advised that the median is used as the more reliable measure of average waiting time, as this accounts better for any outliers in the data</p></td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4"><p><em>Source:</em> Improving Access to Psychological Therapies (IAPT) Dataset, Health and Social Care Information Centre</p></td><td> </td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p>The Government has announced the first ever access and waiting standards for mental health services for 2015/16. These standards will include treatment within six weeks for 75% of people referred to IAPT, with 95% of people being treated within 18 weeks.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 09/03/2015 16:06:43 answering member 1439 label Biography information for Norman Lamb
	tabling member	432 label Biography information for Helen Jones

225194

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dental Services: North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many full-time equivalent dental surgeons there were per head of population in (a) Warrington and (b) the North-West in each year since 2010.
	tabling member constituency	Warrington North
	tabling member printed	Helen Jones
	type	WrittenParliamentaryQuestion
	uin	226420
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>There are now over 7,500 more nurses, midwives and health visitors working in the National Health Service than in May 2010.</p><p> </p><p> </p><p> </p><p>The information is not available in the format requested. Information such as is available is shown in the attached table.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 09/03/2015 17:32:53 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name NHS Hospital and Community Health Services.docx title Dental surgeons FTE in Area Teams in North West
	tabling member	432 label Biography information for Helen Jones

224730

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cystic Fibrosis: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to his plans to devolve health and social care provision and expenditure to Greater Manchester, what safeguards will be put in place to protect the national standards for cystic fibrosis care created by the national commissioning of specialised services when that devolution of powers has taken place.
	tabling member constituency	Stretford and Urmston
	tabling member printed	Kate Green
	type	WrittenParliamentaryQuestion
	uin	225974
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>This is a historic partnership between local organisations in Greater Manchester, with general practitioners as clinical leaders working with elected leaders to improve services for people living in the area.</p><p> </p><p> </p><p> </p><p>The National Health Service bodies involved, including NHS England and the relevant clinical commissioning groups (CCGs), will remain accountable for the exercise of their functions, including the commissioning of specialised services.</p><p> </p><p> </p><p> </p><p>During 2015/16 funding arrangements will not change. However from April 2016, CCGs, local authorities and NHS England intend to pool even greater resources to allow integrated, local decision-making. There may be some exceptions to the services and funding streams which are in Scope but this detail is being worked through between the partners.</p><p> </p><p> </p><p> </p><p>The fundamental national policies, inspection regimes, guidance and regulations will continue to apply to Greater Manchester but, in line with the Five Year Forward View published by NHS England, Greater Manchester will exercise greater freedom in how they are implemented so that local services better reflect the priorities of local patients and service users.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 225904 question first answered 09/03/2015 17:42:56 answering member 1439 label Biography information for Norman Lamb
	tabling member	4120 label Biography information for Kate Green

222791

	registered interest
	date	23/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	IVF
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 8 January 2014 (HC Deb, col 267–8W), what sort of abnormalities might be anticipated in offspring conceived via pronuclear transfer or spindle-chromosomal complex transfer that would need to be assessed in follow-up studies; what sample size for either embryos transferred or neonates would need to be evaluated before deciding that too many abnormalities were observed; how the general public would be informed of the number of abortions that might take place under statutory ground E of the Abortion Act 1967 specifically following attempts at either pronuclear transfer or spindle-chromosomal complex transfer; and how many abnormalities would need to be seen before the programme was stopped.
	tabling member printed	Lord Alton of Liverpool
	type	WrittenParliamentaryQuestion
	uin	HL5132
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that the 2011, 2013, and 2014 reports: <em>Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception</em> have not found evidence that use of pronuclear transfer (PNT) or maternal spindle transfer (MST) results in abnormalities.</p><p> </p><p> </p><p> </p><p>However, the HFEA would expect that the health of all babies born following PNT and MST would be assessed at birth and in long term follow-up studies and that these assessments would identify any abnormalities where they are present.</p><p> </p><p> </p><p> </p><p>The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 will not come into force until 29 October 2015. The HFEA will announce its proposals for the regulation, monitoring and reporting of mitochondrial donation treatment cycles in due course.</p><p> </p> answering member printed Earl Howe question first answered 09/03/2015 16:18:27 answering member 2000 label Biography information for Earl Howe
	tabling member	738 label Biography information for Lord Alton of Liverpool

222792

	registered interest
	date	23/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	IVF
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the remarks by Lord Wallace of Saltaire on 11 February (HL Deb, col 1243), what consideration both they and the Human Fertilisation and Embryology Authority have given to the patent applications by Scott Webster Ballinger, Danny R. Welch, Robert Allen Kesterson and Larry W. Johnson (US20090328241, US 13/360,344) and by Shoukhrat M. Mitalipov (US20120036591, US 13/265,326); and what is their estimation of the potential impact of such patent applications on the promotion of economic growth by licensing the first clinical applications in the United Kingdom of (1) pronuclear transfer, and (2) spindle-chromosomal complex transfer.
	tabling member printed	Lord Alton of Liverpool
	type	WrittenParliamentaryQuestion
	uin	HL5133
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>Neither the Government nor the Human Fertilisation and Embryology Authority has made any such assessment.</p><p> </p> answering member printed Earl Howe question first answered 09/03/2015 16:12:38 answering member 2000 label Biography information for Earl Howe
	tabling member	738 label Biography information for Lord Alton of Liverpool